...
首页> 外文期刊>Polymers >A Polyvinylpyrrolidone-Based Supersaturable Self-Emulsifying Drug Delivery System for Enhanced Dissolution of Cyclosporine A
【24h】

A Polyvinylpyrrolidone-Based Supersaturable Self-Emulsifying Drug Delivery System for Enhanced Dissolution of Cyclosporine A

机译:基于聚乙烯吡咯烷酮的过饱和自乳化递药系统,用于增强环孢霉素A的溶解

获取原文
           

摘要

A novel supersaturable self-emulsifying drug delivery system (S-SEDDS) of cyclosporine A (CyA)—a poorly water-soluble immunosuppressant—was constructed in order to attain an apparent concentration–time profile comparable to that of conventional SEDDS with reduced use of oil, surfactant, and cosolvent. Several hydrophilic polymers, including polyvinylpyrrolidone (PVP), were employed as precipitation inhibitors in the conventional SEDDS, which consists of corn oil-mono-di-triglycerides, polyoxyl 40 hydrogenated castor oil, ethanol, and propylene glycol. PVP-incorporated pre-concentrate (CyA:vehicle ingredients:PVP = 1:4.5:0.3 w/v/w) spontaneously formed spherical droplets less than 120 nm within 7 min of being diluted with water. In an in vitro dialysis test in a biorelevant medium such as simulated fed and/or fasted state intestinal and/or gastric fluids, PVP-based S-SEDDS exhibited a higher apparent drug concentration profile compared to cellulose derivative-incorporated S-SEDDS, even displaying an equivalent concentration profile with that of conventional SEDDS prepared with two times more vehicle (CyA:vehicle ingredients = 1:9 w/v). The supersaturable formulation was physicochemically stable under an accelerated condition (40 °C/75% RH) over 6 months. Therefore, the novel formulation is expected to be a substitute for conventional SEDDS, offering a supersaturated state of the poorly water-soluble calcinurin inhibitor with a reduced use of vehicle ingredients.
机译:构建了新型的环孢霉素A(CyA)的超饱和自乳化药物递送系统(S-SEDDS)(水溶性差的免疫抑制剂),以达到与传统SEDDS相当的浓度-时间分布特征,并减少了使用油,表面活性剂和助溶剂。在传统的SEDDS中,几种亲水性聚合物(包括聚乙烯吡咯烷酮(PVP))被用作沉淀抑制剂,它由玉米油-单-二甘油三酸酯,聚羟基40氢化蓖麻油,乙醇和丙二醇组成。掺有PVP的预浓缩液(CyA:车辆成分:PVP = 1:4.5:0.3 w / v / w)在用水稀释后7分钟内自发形成小于120 nm的球形液滴。在生物相关介质(如模拟的进食和/或禁食状态的肠和/或胃液)中进行的体外透析测试中,与掺有纤维素衍生物的S-SEDDS相比,基于PVP的S-SEDDS表现出更高的表观药物浓度分布,甚至显示出与传统SEDDS相同的浓度曲线,而传统的SEDDS则用两倍以上的载体制备(CyA:车辆成分= 1:9 w / v)。过饱和制剂在加速条件下(40°C / 75%RH)在6个月内物理化学稳定。因此,该新型制剂有望替代常规的SEDDS,从而提供水溶性较差的钙调神经磷酸酶抑制剂的过饱和状态,并减少了载体成分的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号